Abstrak
Leprosy is still a major public health problem in Indonesia as well as in the world. The number of leprosy cases in Indonesia could be classifi ed as number three in the world after India and Brazil. 1 The number of new leprosy patients tends to increase since there is a possibility that seropositive leprosy is turning into manifest leprosy. Seropositive leprosy is a condition when someone is infected by M. Leprae, however, they have not shown any clinical symptoms. More than half of healthy inhabitants in endemic leprosy area are anti-micro bacterial antibody positive. Therefore seropositive leprosy should get more attention in the effort to eliminate leprosy. Detection of seropositive leprosy subjects can be done by using various methods; one of them is by examining Immunoglobulin M (IgM) anti Phenolic Glycolipid (PGL)-1 level. 2 Cellular immune response level will determine leprosy spectrum. For leprosy pausibasiler type (PB), the cellular immunity is still good; however for leprosy multibasiler type (MB), the cellular immunity is decreased.
3 Some researches showed that the immune response was infl uenced by micro nutrients such as zinc. 4 Zinc serum level, which may determine leprosy spectrum, plays a role in the cellular immune response. Some research results showed gradual decrease in zinc serum level on the transition of leper type PB to MB. The lowest level is found in MB type.
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Zinc plays a role in cytokine production such as interferon (IFN)-γ, interleukin (IL)-2, and Tumor Necrosis Factor (TNF)-α. T-helper 1 (Th1) cytokine products, such as IFN-γ and IL-2 are decreased in zinc defi ciency. IFN-γ and IL-2 production is improved when zinc level is maintained to be suffi cient by giving zinc supplement. 6 Seropositive contacts of leprosy patients have a tendency to change into leprosy multibasiler type (MB). Cellular immunity of leprosy MB is decreased or even reaches anergy, and it turns into humoral immunity (Th2), which makes the patient's condition worse. Therefore, this study aimed to analyze the infl uence of zinc supplementation on interleukin 2 (IL-2) level of seropositive contact of leprosy patients with marginal zinc defi ciency. Zinc supplementation is expected to increase IL-2, and in turn will maintain the function of cellular immunity in seropositive leprosy.
METHODS
This study was conducted on people who live in the same house or near the leper population in Brondong subdistric, Lamongan regency, East Java, Indonesia in 2010. The amount of the research sample was predetermined, i.e. 22 subjects who were randomly chosen from those who met the inclusion criteria. The ethical clearance for this study was obtained from Research and Public Service Institute, Airlangga University no. 071/PANEC/LPPM/2009.
Inclusion criteria
The inclusion criteria were individuals of 20 to 40 years old (both male and female) whom were proven to be leprosy serology positive (IgM anti PGL-1 level is 600 -1500 unit/ml) and had marginal zinc status (zinc plasma level 10.7 -13.0 μmol/L). In addition, they did not clinically show any leprosy symptoms and did not consume anti-leprosy medicine. They also did not have any disease, which might infl uence their zinc status, did not suffer from tuberculosis and did not consume any anti-tuberculosis drugs; they did not consume any anti-immunosuppressant in the last three months before blood samples were taken; their body mass indexes were more than 18 kg/m2 and were willing to join the study by signing an informed consent form.
Zinc supplementation
Those 22 subjects were randomly assigned in pairs to receive either zinc-supplement (treatment group) or placebo (placebo group). Each day for 3 months, subjects in the treatment group received 1 capsule of zinc sulfate (40 mg elemental zinc), while subjects in the placebo group received placebo capsules in the same manner. The obedience of consuming supplement was monitored by the researchers and local health staff.
Procedures
Plasma zinc levels were measured by using atomic absorption spectrophotometer in Balai Besar Laboratorium Kesehatan Surabaya. Determination of seropositive leprosy was done by examining IgM anti PGl-1 level by enzyme-linked immunosorbent assay using polyclonal rabbit anti human IgM/HRP secondary antibody (Dako ® ). The assay was developed in the Institute Tropical Disease Laboratory, Airlangga University, Surabaya. In addition, daily intake was measured using recall method and food frequency questionnaire, and IL-2 measurements on peripheral blood mononuclear cells in cultures were done.
Peripheral blood mononuclear cell culture and IL2 measurements
Peripheral blood mononuclear cells (3 x 10 -7 g/μl per well) were stimulated with a mitogen (Dharmendra lepromins) in culture for 2 days in 10% CO 2 at 37 0 C. Supernatant was collected from lepromin-stimulated cell culture, and the IL-2 level was measured by using commercial enzyme-linked immunosorbent assay kits (Quantikine ® catalog number D2050, R&D System, Inc Minneapolis, USA) in Pathology laboratory of Dr. Soetomo hospital, Surabaya. Concentrations of IL-2 were expressed as pg/mL supernatant.
Data collection and analysis
Data collected were characteristics of the sample, daily intake, and anti PGL-1 IgM. In addition, data of plasma zinc and IL-2 levels before and after supplementation were also collected. All data were noted and tabulated. Normality of the data was determined by the KolmogorovSmirnov test. Statistical analyses were done using SPSS 16 statistical software, to compare plasma zinc and IL-2 level between treatment and placebo group by independent t test. Further, paired t test was used to compare plasma zinc as well as IL-2 levels of before and after supplementation. Fisher's exact was used to compare the two sexes between groups.
RESULTS
To know whether someone was leprosy seropositive, a serology test (IgM anti PGL-1) was conducted on 153 subjects who live in the same house with a leprosy patient or near the leper population. The average level of IgM anti PGL-1 was 1047 pg/mL (± 823.6). The examination results showed that 78 subjects (51%) were leprosy seropositive on the level of 600 -1500 pg/ml. Next, zinc plasma examination was done. The average level of zinc plasma on those subjects was 13.9 μmol/L (± 1.98). From the 78 seropositive subjects, 30 (37.7%) experienced marginal zinc defi ciency (zinc plasma level 10.7 -13.0 μmol/L).
The comparative result showed that there was no signifi cant difference of sex, body mass index and IgM PGL-1 level between both groups (table 1). Further, there was no difference in daily intake between the two groups (Data not shown).
On placebo group, the average of zinc plasma level was relatively the same at the beginning and the end of the study (p= 0.133). However, there was a major increase in zinc plasma level on treatment group (p= 0.001). There was no signifi cant difference between the treatment and placebo group in baseline plasma zinc level (p= 0.823) and 3 months after treatment (p = 0.819). However, there was signifi cant difference in the change of zinc plasma level between both groups (p = 0.002) ( Table 2) .
On placebo group, IL-2 level after 3 months was signifi cantly lower than baseline (p= 0.025). However, on treatment group, IL-2 level was relatively stable (p= 0.721). There was a signifi cant difference between the treatment and placebo group in IL-2 concentration at baseline (p= 0.032), but after 3 months of treatment there was no signifi cant difference (p= 0.750). Conversely, there was signifi cant change of IL-2 level between the two groups (p= 0.037) ( Table 3) .
DISCUSSION
Screening results showed that 51 % of inhabitants in Brondong sub district, Lamongan regency, East Java, were leprosy seropositive based on IgM anti PGL-1 examination. This fi nding is higher than that in South Korea that was 12.1 % and in the Philippines that was 13.9%. 7 However, this fi nding is relatively the same compared to that in Semarang, Central Java, namely 53%.
8 Indonesia has a higher prevalence of seropositive leprosy; this fact corresponds with the number of leprosy cases in Indonesia that could be classifi ed as number three in the world after India and Brazil. Zinc supplementation on leprosy seropositive subjects for three months was proven to be able to prevent the decrease in IL -2 level, since zinc can give infl uence on T-cell signal transduction that started from the proximal (cell membrane) level to the distal level (nucleolus transcription).
On proximal level, this fact can be explained since zinc has an effect on lymphocyte protein tyrosine kinase (Lck). On the next signal transduction, zinc infl uences protein kinase C and extracellular-signal regulated kinase (Erk). Zinc is needed for homodimerization and heterodimerization of Lck. Zinc capability on homodimerization and heterodimerization was specifi c for Lck. This capability was due to cystein residues, which form two intermolecular zinc binding-sites that are unique and are not present in other Scr kinase family members.
9 Protein kinase C also causes nuclear factor kappa B (NFκB) to be free from its bond in the cytoplasma and then entered the nucleus. Zinc has an effect on the activation of inhibitor kB (IκB) kinase and the expression of mRNA p105 (prekursor NFκB p50). Then, zinc also infl uences the phosphorylation and ubiquitination process on IκB, so that it is degraded, and makes it possible to translocate NFκB from cytosol to the nucleus. Next, NFκB connects with DNA and then, IL-2 mRNA transcription process happens. If the T-cell signal transduction runs well, transcription factors such as nuclear factor of activated T-cells (NFAT), NFκB and activator protein-1 (AP-1) that control IL -2 gene transcription will work well.
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Signifi cant decrease of IL-2 level on placebo group can be explained since Mycobacterium leprae is able to destroy T-cell signal transduction, which causes T-cell proliferation decrease. Mycobacterium leprae defects the activities of jun-NH2-terminal kinase (JNK) and ERK. The defected activities of JNK and ERK will cause the decreased activity of AP-1. Moreover, there are also reduced calcium levels, protein kinase C activity and calcineurin activity. Lower calcium level, activities of protein kinase C and calcineurin can interfere with the transcription factors of NFAT and NFkB.
13
Mycobacterium leprae can interfere with host immune response by lowering costimulatory molecules activity of host cell. The expression of B7-1 and CD 28 were signifi cantly decreased in patients with untreated lepromatous leprosy disease. Down regulation of B7-1 and CD 28 in lepromatous leprosy may be responsible for a defective T cell signaling by the B7-1/CD 28 pathway due to M. leprae antigens.
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In conclusion, Zinc supplementation could modulate T cell to maintain IL-2 level production in leprosy seropositive subjects with marginal zinc defi ciency.
